Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
17 November 2017 09:18
It's estimated 8,000 women could benefit from the drugs
Women diagnosed with untreatable breast cancer are being given fresh hope, with the approval of two new "breakthrough" medicines for widespread use across England's health service.
The National Institute for Health and Care Excellence (Nice) has approved NHS use of palbociclib and ribociclib - drugs that are shown to slow down advance cancer and delay the need for chemotherapy.
Nice - which has rejected palbociclib in the past because of its high cost - has announced the new agreement after negotiating a new lower price with manufactured Pfizer.
A life-changing breakthrough
Around 45,000 women receive new diagnoses of breast cancer each year in England, and it's estimated 8,000 women could benefit from the ground-breaking treatment.
Nicholas Turner, trial lead and professor of molecular oncology at the Institute of Cancer Research (ICR) in London and consultant medical oncologist at the Royal Marsden, says: "The development of this brand new class of cancer drug is one of the most important breakthroughs for women with advanced breast cancer in the last two decades.
"In clinical trials, palbociclib and ribociclib have made a huge difference to women's lives - slowing down tumour growth for nearly a year, and delaying the need for chemotherapy with all its potentially debilitating side-effects. These drugs have allowed women to live a normal life for longer."
Treatment for women of any age
Women who are pre-menopausal and have been diagnosed with oestrogen receptor positive breast cancer after it the disease has spread will be eligible for palbociclib.
Post-menopausal women diagnosed who are diagnosed under the same conditions will be treated with ribociclib, manufactured by Novartis.
Both drugs work in a similar way, and are shown to hold back breast cancer for at least 10 months, affording women a normal life for longer.
Even if your cancer has spread, if you have had chemotherapy in the last three months, are taking strong painkillers or have a terminal prognosis, we may still be able to cover you for holidays and overseas travel with our specialist cancer travel insurance.
19 October 2018
Pregnant women who suffer from pre-eclampsia have a greater risk of developing dementia, new research suggests.
[more...]
18 October 2018
The UK's average life expectancy is predicted to increase from 80.8 years to 83.3 years over the next 20 years, according to new research.
17 October 2018
Family doctors are being urged to prescribe physical activity for patients living with some of the most common medical conditions.
16 October 2018
Patients with brain tumours lose out on almost £15,000 per year, a new report has revealed.
13 October 2018
Chris Grayling has given his "categorial assurance" to Parliament that a no-deal Brexit will not ground flights in and out of the UK, despite recent warnings from experts that this remains a possibility.
12 October 2018
The rising cost of fuel could force more airlines out of business, the boss of easyJet has warned.
11 October 2018
The image of the boozy backpacker might be a thing of the past as a new study suggests more and more youngsters are shunning alcohol completely.
10 October 2018
The NHS says just one in 10 drinks sold in English hospitals will be sugar-sweetened, as part of its bid to curb rising obesity levels.
09 October 2018
More than 260,000 diabetes patients were put at risk of lasting harm or even death during hospital stays last year due to medication errors, a new report has revealed.
06 October 2018
NHS patients with a specific type of lymphoma will soon be able to access a "game-changing" new treatment, health officials have revealed.
05 October 2018
People living with diabetes are being warned they might be "unwittingly" storing their insulin incorrectly.
04 October 2018
The world's first commercial jet part-powered by a new form of biofuel touches down in London on Wednesday (3rd October).